Table 2.
Specification of donor screening
| Faeces screening | |
| Calprotectine | |
| Bacteria | |
| Clostridium difficile | Yersinia enterocolitica |
| Helicobacter pylori | Plesiomonas shigelloides |
| Salmonella sp | Pathogenic Campylobacter sp |
| Shigella sp | Shiga toxin-producing Escherichia coli |
| Antibiotic-resistant bacteria | |
| Vancomycin-resistant Enterococcus | Multidrug-resistant Gram-negative (MRGN) 3 |
| Carbapenem-resistant Enterobacteriaceae | MRGN 4 |
| Methicillin-resistant Staphylococcus aureus | Extended spectrum beta-lactamase-producing Enterobactereacceae |
| Viruses | |
| Hepatitis E | Rotavirus |
| Norovirus type I and II | Enterovirus |
| Astrovirus | Adenovirus non-41/41 |
| Sapovirus | Parechovirus |
| Adenovirus type 40/41 | COVID-19 |
| Parasites | |
| Giardia lamblia | Microsporidium sp |
| Cryptosporidium sp | Blastocystis hominis* |
| Entamoeba histolytica | Isospora sp |
| Dientamoeba fragilis | Cyclospora |
| Non-pathogenic parasites† | |
| Entamoeba gingivalis | Endolimax nana |
| Entamoeba hartmanni | Iodamoeba bütschlii |
| Entamoeba coli | Entamoeba dispar |
| Entamoeba polecki | Entamoeba moshkovskii |
| Other | |
| Parasitic worm eggs | Protozoan cysts and oocysts |
| Larvae | |
| Serum screening | |
| Haematology | |
| Complete blood count | Gamma-glutamyl transferase |
| Bilirubine | Alkaline phosphatase |
| C-reactive protein | Kreatinine |
| Aspartate aminotransferase | Ureum |
| Alanine aminotransferase | Estimated glomerular filtration rate |
| Bacteria | |
| Lues | |
| Viruses | |
| Hepatitis A | Cytomegalovirus |
| Hepatitis B | Epstein-Barr virus |
| Hepatitis C | Human T-lymphotropic virus |
| HIV | |
| Parasites | |
| Strongyloides | |
*Exclusion of donor only if microscopically ‘much’ or ‘very much’ blastocystis are seen.
†Presence of only one non-pathogenic parasite is acceptable.